One in Two

This World Cancer Day 2023, we speak to Professor Robert Bristow, the Director of the Manchester Cancer Research Centre, Chief Academic Officer at The Christie NHS Foundation Trust and Professor of Cancer Studies at The University of Manchester about his research in prostate cancer. We also cover the broader cancer research environment in Manchester, the importance of teamwork and team science and research, and delivering impact through internationalisation.   Professor Robert Bristow’s profile: https://www.bmh.manchester.ac.uk/about/people/leadership/robert-bistow/ Listen to Dr Martin Swinton explain the HYPROGEN trial: CRUK RadNet Manchester. -The HYPROGEN Trial with Dr Martin Swinton

Show Notes

This World Cancer Day 2023, we speak to Professor Robert Bristow, the Director of the Manchester Cancer Research Centre, Chief Academic Officer at The Christie NHS Foundation Trust and Professor of Cancer Studies at The University of Manchester about his research in prostate cancer.
We also cover the broader cancer research environment in Manchester, the importance of teamwork and team science and research, and delivering impact through internationalisation.
 
Professor Robert Bristow’s profile:  https://www.bmh.manchester.ac.uk/about/people/leadership/robert-bistow/
Listen to Dr Martin Swinton explain the HYPROGEN trial: CRUK RadNet Manchester. -The HYPROGEN Trial with Dr Martin Swinton

What is One in Two?

With one in two of us receiving a cancer diagnosis at some point during our lives, it has never been more important to improve the outcomes for people affected by cancer.

This cancer research podcast is brought to you by The University of Manchester in partnership with the Manchester Cancer Research Centre (MCRC). In each episode, our cancer researchers discuss the innovations, discoveries and projects that are changing the landscape of early detection.